Search results for "Cancer Drug"

InduPro Secures $77M Series B, Launches First Human Cancer Trial

Biotech startup InduPro has secured $77 million in Series B funding and commenced its first human clinical trial for lead cancer drug IDP-001. The company's novel proximity-guided platform aims to precisely target tumors by identifying specific protein combinations on cancer cell surfaces, sparing healthy tissue. This milestone, alongside a significant Eli Lilly partnership, marks a pivotal step for the Seattle and Cambridge-based firm.